Zinc-Induced PKCδ-dependent Phosphorylation of MTF-1 Promotes Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension
International Journal of Biological Sciences · 2026
DOI: 10.7150/ijbs.124664 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Ai Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Fujian Hypertension Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Protein Kinase C-delta, DNA-Binding Proteins, Zinc. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pulmonary hypertension (PH) is driven by pulmonary vascular remodeling, in which the zinc-sensing transcription factor metal-responsive transcription factor 1 (MTF-1) may play a pivotal regulatory role.Rodent models of hypoxia-induced PH and cultured pulmonary arterial smooth muscle cells (PASMCs) were used to investigate zinc-mediated MTF-1 activation.Phos-tag SDS-PAGE, site-directed mutagenesis, Cleavage Under Targets and Tagmentation (CUT&Tag), and pharmacological inhibitors were employed to dissect the PKCδ/MTF-1/placental growth factor (PlGF) pathway.CUT&Tag profiling revealed prominent MTF-1 enrichment at promoter regions under hypoxia, with significant occupancy at the Plgf locus and enrichment of angiogenesis-related genes.Hypoxia increased intracellular zinc levels, activated PKCδ, and triggered phosphorylation of MTF-1 at Ser 304 .This modification was essential for MTF-1 nuclear translocation and PlGF transcription.Mutation of Ser 304 or MTF-1 knockdown suppressed PASMCs proliferation and migration under hypoxia and zinc exposure.Gö 6983 abrogated MTF-1 phosphorylation and downstream responses, and selective knockdown of PKCδ reproduced these effects, confirming PKCδ as the predominant isoform mediating MTF-1 activation.In vivo, MTF-1 and PlGF were upregulated in pulmonary vessels of Su/Hx-PH rats, while APTO-253 treatment attenuated pulmonary vascular remodeling and improved cardiopulmonary hemodynamics in hypoxic mice.This study identified PKCδ-dependent phosphorylation of MTF-1 at Ser 304 as a critical mechanism linking zinc accumulation to PlGF-driven PASMCs proliferation.Targeting the zinc/PKCδ/MTF-1/PlGF axis represented a novel therapeutic strategy for hypoxic PH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Fujian Hypertension Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- International Medical Department, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China.
- Department of Cardiology, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
Zitieren
APA
Chen, A., Yan, Y., Cao, R., Cai, K., Lian, G., Cai, W., Zhou, J., & Xie, L. (2026). Zinc-Induced PKCδ-dependent Phosphorylation of MTF-1 Promotes Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.124664
Vancouver
Chen A, Yan Y, Cao R, Cai K, Lian G, Cai W, et al. Zinc-Induced PKCδ-dependent Phosphorylation of MTF-1 Promotes Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.124664
BibTeX
@article{Chen2026,
author = {Chen, Ai and Yan, Yan and Cao, Rong and Cai, Kexin and Lian, Guili and Cai, Wenqin and Zhou, Jianfu and Xie, Liangdi},
title = {Zinc-Induced PKCδ-dependent Phosphorylation of MTF-1 Promotes Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension},
journal = {International Journal of Biological Sciences},
year = {2026},
doi = {10.7150/ijbs.124664}
}
EUVIMED